IM Cannabis Corp. Regains Nasdaq Equity Compliance

TL;DR

IM Cannabis Corp. back in Nasdaq's good graces, equity compliance restored.

AI Summary

On September 5, 2025, IM Cannabis Corp. announced it has regained compliance with the Nasdaq Stockholders' Equity Listing Requirement. This is a significant development for the company as it allows them to continue trading on the Nasdaq Stock Market.

Why It Matters

Regaining compliance with Nasdaq's equity requirement is crucial for IM Cannabis Corp. as it ensures continued listing on the exchange, providing liquidity and investor confidence.

Risk Assessment

Risk Level: medium — While regaining compliance is positive, the company's financial health and ability to maintain this status going forward present ongoing risks.

Key Players & Entities

• IM Cannabis Corp. (company) — Registrant
• Nasdaq (company) — Stock Exchange
• September 5, 2025 (date) — Date of press release

FAQ

From the Filing

0001178913-25-003251.txt : 20250905 0001178913-25-003251.hdr.sgml : 20250905 20250905072751 ACCESSION NUMBER: 0001178913-25-003251 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20250905 FILED AS OF DATE: 20250905 DATE AS OF CHANGE: 20250905 FILER: COMPANY DATA: COMPANY CONFORMED NAME: IM Cannabis Corp. CENTRAL INDEX KEY: 0001792030 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40065 FILM NUMBER: 251295001 BUSINESS ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 BUSINESS PHONE: 416-256-4202 MAIL ADDRESS: STREET 1: KIBBUTZ GLIL YAM CITY: CENTRAL DISTRICT STATE: L3 ZIP: 4690500 6-K 1 zk2533761.htm 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of September 2025   Commission File Number: 001-40065 IM Cannabis Corp. (Exact Name of Registrant as Specified in Charter) 3606 – 833 Seymour Street, Vancouver, British Columbia V6B 0G4 (Address of principal executive offices)   Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F ☒     Form 40-F ☐   CONTENTS   On September 5, 2025, IM Cannabis Corp. (the “Company”) issued a press release titled: “IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement”. A copy of this press release is furnished herewith as Exhibit 99.1.   This Report of Foreign Private Issuer on Form 6-K is incorporated by reference into the Company’s Registration Statements on Form F-3 (File No. 333-289571 and 333-288346 ) filed with the Securities and Exchange Commission to be a part thereof from the date on which this Report of Foreign Private Issuer on Form 6-K is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.   EXHIBIT INDEX   Exhibit No.   99.1 Press Release dated September 5, 2025, titled “IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement”.   SIGNATURE   Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.       IM CANNABIS CORP.     (Registrant)         Date: September 5, 2025 By: /s/Oren Shuster     Name: Oren Shuster     Title: Chief Executive Officer and Director EX-99.1 2 exhibit_99-1.htm EXHIBIT 99.1 Exhibit 99.1 IM Cannabis Regains Compliance with Nasdaq Stockholders’ Equity Listing Requirement   TORONTO and GLIL YAM, Israel, September 5, 2025/CNW/ -- IM Cannabis Corp. (NASDAQ: IMCC) (the “ Company ”, “ IM Cannabis ”, or “ IMC ”), a leading medical cannabis company with operations in Israel and Germany, today announced that it received notice from Nasdaq on September 4, 2025 that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000. The Company’s common stock will continue to be listed and traded on the Nasdaq Capital Market.   About IM Cannabis Corp.   IMC (Nasdaq: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an